Thorne HealthTech, Inc. (“Thorne HealthTech” or “Thorne”) (NASDAQ:THRN), a leader in developing innovative solutions for a personalized approach to health and wellbeing, today announced it has agreed to form a joint venture with Mitsui & Co., Ltd. (“Mitsui”) called Thorne HealthTech Asia Pte. Ltd. (“Thorne Asia”). Thorne Asia will drive awareness of, and expand access to, Thorne’s leading innovative solutions and personalized approaches to address health and wellbeing across Asia. Thorne Asia will promote and provide Thorne’s diagnostics, analytics, and supplement offerings online, as well as through medical and retail providers, and utilize Mitsui’s business professional healthcare and consumer retail expertise and relationships in the region.
AstraZeneca, EU Reach Settlement On COVID-19 Vaccine Delivery
AstraZeneca Plc (NASDAQ:AZN) and the European Commission have settled on the delivery of pending COVID-19 vaccine doses by the Company. The…